Ads
related to: moderna stock- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Trade
Search results
Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise By Investing.com
Investing.com· 7 days agoSalesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters· 7 days ago, opens new tab mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak...
The U.S. Government Is Close To Bankrolling Moderna's Bird Flu Jab
Investor's Business Daily· 6 days agoThe Centers for Disease Control and Prevention classifies the public health risk as low. A Moderna...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 hours agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) ( ...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 12 hours agoNovavax, Inc. NVAX shares are trading higher Wednesday, and the stock is up by more than 300% over...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 3 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks via Yahoo Finance· 7 days agoModerna is a commercial-stage pharmaceutical company primarily focused on discovering and developing...
Moderna wins second product approval with RSV vaccine
Market Watch· 6 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...